University of Wisconsin–Madison

Elaine Morlock, Phd

Patent Agent, Klarquist Sparkman, LLP

elaine.morlock@gmail.com

Advisor: Dr. Cynthia Czajkowski

Graduation: 06/2012

Elaine Morlock

Alumni News

January 2017: Patent Agent at Klarquist

September 2012: Elaine became a patent technology specialist. Job Duty: writing patent applications for a small intellectual property law firm in Portland, OR.

Specializations

  • Certificated Emergency Medical Technician

Awards & Honors

  • Molecular and Cellular Pharmacology Program Travel Award. Full funding to attend and present at American Society for Pharmacology and Experimental Therapeutics annual meeting (April 2012)
  • Best Molecular and Cellular Pharmacology Seminar (2011)
  • Vilas Travel Award (2011)
  • Ruth L. Kirschstein National Research Service Award NIH Predoctoral Fellowship. 2010-2012.

Skills: Western Blotting and Molecular Biology

Publications

  • Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, Wu X, and Karagas MR (2012). HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. PLoS One. 7:e51301. Epub 2012 Dec 19. PMCID: PMC3526593
  • Morlock EV and Czajkowski C (2011). Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding.Mol Pharmacol. 80:14-22. PMCID: PMC3127544
  • Mason RA, Morlock EV, Karagas MR, Kelsey KT, Marsit CJ, Schned AR, and Andrew AS (2009). EGFR Pathway Polymorphisms and Bladder Cancer Susceptibility and Prognosis. Carcinogenesis. 30:1155-1160. PMCID: PMC2704279
  • Andrew AS, Kelsey KT, Gui J, Morlock EV, Mason RA, Moore JH, and Karagas MR. (2009) Bladder cancer SNP panel predicts susceptibility and survival. Hum. Genet. 125:527-539. PMCID: PMC2763504
  • Hanson SM, Morlock EV, Satyshur KA, Czajkowski C (2008). Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem. 51:7243-52. PMCID: PMC2645942